198 related articles for article (PubMed ID: 34338111)
1. Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway.
Støer NC; Bouche G; Pantziarka P; Sloan EK; Andreassen BK; Botteri E
Acta Oncol; 2021 Sep; 60(9):1146-1153. PubMed ID: 34338111
[TBL] [Abstract][Full Text] [Related]
2. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
[No Abstract] [Full Text] [Related]
3. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
Löfling LL; Støer NC; Andreassen BK; Ursin G; Botteri E
Breast Cancer Res; 2023 Aug; 25(1):101. PubMed ID: 37649039
[TBL] [Abstract][Full Text] [Related]
4. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
[TBL] [Abstract][Full Text] [Related]
5. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
6. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.
Jian-Yu E ; Graber JM; Lu SE; Lin Y; Lu-Yao G; Tan XL
Curr Med Chem; 2018; 25(22):2595-2607. PubMed ID: 28403788
[TBL] [Abstract][Full Text] [Related]
7. Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study.
Alexandre L; Clark AB; Bhutta HY; Chan SS; Lewis MP; Hart AR
Gastroenterology; 2016 Apr; 150(4):854-65.e1; quiz e16-7. PubMed ID: 26775632
[TBL] [Abstract][Full Text] [Related]
8. Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.
Hamada T; Khalaf N; Yuan C; Morales-Oyarvide V; Babic A; Nowak JA; Qian ZR; Ng K; Rubinson DA; Kraft P; Giovannucci EL; Stampfer MJ; Fuchs CS; Ogino S; Wolpin BM
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1300-1306.e3. PubMed ID: 29474971
[TBL] [Abstract][Full Text] [Related]
9. Statin use and mortality among endometrial cancer patients: a Danish nationwide cohort study.
Sperling CD; Verdoodt F; Kjaer Hansen M; Dehlendorff C; Friis S; Kjaer SK
Int J Cancer; 2018 Dec; 143(11):2668-2676. PubMed ID: 29923185
[TBL] [Abstract][Full Text] [Related]
10. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
Joentausta RM; Rannikko A; Murtola TJ
Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
[TBL] [Abstract][Full Text] [Related]
12. Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study.
Zheng J; Santoni G; Xie SH; Lagergren J
Br J Cancer; 2021 Jul; 125(2):277-283. PubMed ID: 33972744
[TBL] [Abstract][Full Text] [Related]
13. Statins and pancreatic cancer risk in patients with chronic pancreatitis: A Danish nationwide population-based cohort study.
Kirkegård J; Lund JL; Mortensen FV; Cronin-Fenton D
Int J Cancer; 2020 Feb; 146(3):610-616. PubMed ID: 30861115
[TBL] [Abstract][Full Text] [Related]
14. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
[TBL] [Abstract][Full Text] [Related]
15. Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study.
Kirkegård J; Cronin-Fenton D; Lund A; Mortensen FV
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5726. PubMed ID: 37946571
[TBL] [Abstract][Full Text] [Related]
16. Statin Use and Its Impact on Survival in Pancreatic Cancer Patients.
Lee HS; Lee SH; Lee HJ; Chung MJ; Park JY; Park SW; Song SY; Bang S
Medicine (Baltimore); 2016 May; 95(19):e3607. PubMed ID: 27175667
[TBL] [Abstract][Full Text] [Related]
17. Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma.
Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Cancer Res; 2017 Jul; 77(13):3700-3707. PubMed ID: 28473530
[TBL] [Abstract][Full Text] [Related]
18. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
[TBL] [Abstract][Full Text] [Related]
19. Statin use and breast cancer survival: a nationwide cohort study in Scotland.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
BMC Cancer; 2016 Aug; 16():600. PubMed ID: 27491389
[TBL] [Abstract][Full Text] [Related]
20. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]